Serum Lipid and Glycemic Profile in HARRT-Naïve and HARRT-Exposed HIV Patients in Enugu State, Nigeria: A Case–Control Study
Background: Although highly active antiretroviral therapy (HAART) has improved immunologic and virologic outcomes, as well as the quality of life of human immunodeficiency virus (HIV)-positive patients, it has worsened a wide range of metabolic derangements associated with HIV/AIDS. A wide range of...
Saved in:
| Main Authors: | , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2024-07-01
|
| Series: | International Journal of Medicine and Health Development |
| Subjects: | |
| Online Access: | https://doi.org/10.4103/ijmh.ijmh_15_24 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832586498609774592 |
|---|---|
| author | Esther A. Ekwe Birinus A. Ezeala-Adikaibe Basden Onwubere Julius Okoye Collins Ugwu Chidinma B. Nwatu Ijoma Chinweuba Chidimma Orah-Okpala Raphael Anakwue Oladipupo O. Fasa Celestine C. Okwara Uchechi Q. Arinze Paschal Njoku |
| author_facet | Esther A. Ekwe Birinus A. Ezeala-Adikaibe Basden Onwubere Julius Okoye Collins Ugwu Chidinma B. Nwatu Ijoma Chinweuba Chidimma Orah-Okpala Raphael Anakwue Oladipupo O. Fasa Celestine C. Okwara Uchechi Q. Arinze Paschal Njoku |
| author_sort | Esther A. Ekwe |
| collection | DOAJ |
| description | Background: Although highly active antiretroviral therapy (HAART) has improved immunologic and virologic outcomes, as well as the quality of life of human immunodeficiency virus (HIV)-positive patients, it has worsened a wide range of metabolic derangements associated with HIV/AIDS. A wide range of lipid abnormalities and dysglycemia have been reported in patients on HARRT. Materials and Methods: The study was carried out at the University of Nigeria Teaching Hospital, a tertiary hospital in southeast Nigeria. A fasting venous blood sample was used to check for fasting plasma glucose. Results: Fasting blood glucose was significantly higher in HARRT-exposed individuals (P < 0.01). This is also true for total cholesterol and triglycerides (P < 0.01). High-density lipoprotein (HDL) was significantly higher in HAART-naïve individuals while low-density lipoprotein was higher in the control group. Comparing HAART-exposed patients and HAART-naïve patients, significantly more HAART-naïve patients had lower HDL (abnormal), P = 0.04, odds ratio = 1.57, 95% confidence interval, 1.01–2.45. HAART-naïve patients had higher rates of abnormal results, except for fasting plasma glucose. Conclusion: HAART-exposed and HAART-naïve HIV/AIDS patients have a high level of dyslipidemia compared with normal HIV-negative patients, and this effect is more pronounced in male patients than female patients. There should be increased surveillance for metabolic derangements in these patients at the time of diagnosis and recruitment into the HAART program. There is a need for the treatment of dyslipidemia in such patients. |
| format | Article |
| id | doaj-art-34ea2cd643454026b590ba5973c56775 |
| institution | Kabale University |
| issn | 2635-3695 2667-2863 |
| language | English |
| publishDate | 2024-07-01 |
| publisher | Wolters Kluwer Medknow Publications |
| record_format | Article |
| series | International Journal of Medicine and Health Development |
| spelling | doaj-art-34ea2cd643454026b590ba5973c567752025-01-25T10:09:58ZengWolters Kluwer Medknow PublicationsInternational Journal of Medicine and Health Development2635-36952667-28632024-07-0129320521110.4103/ijmh.ijmh_15_24Serum Lipid and Glycemic Profile in HARRT-Naïve and HARRT-Exposed HIV Patients in Enugu State, Nigeria: A Case–Control StudyEsther A. EkweBirinus A. Ezeala-AdikaibeBasden OnwubereJulius OkoyeCollins UgwuChidinma B. NwatuIjoma ChinweubaChidimma Orah-OkpalaRaphael AnakwueOladipupo O. FasaCelestine C. OkwaraUchechi Q. ArinzePaschal NjokuBackground: Although highly active antiretroviral therapy (HAART) has improved immunologic and virologic outcomes, as well as the quality of life of human immunodeficiency virus (HIV)-positive patients, it has worsened a wide range of metabolic derangements associated with HIV/AIDS. A wide range of lipid abnormalities and dysglycemia have been reported in patients on HARRT. Materials and Methods: The study was carried out at the University of Nigeria Teaching Hospital, a tertiary hospital in southeast Nigeria. A fasting venous blood sample was used to check for fasting plasma glucose. Results: Fasting blood glucose was significantly higher in HARRT-exposed individuals (P < 0.01). This is also true for total cholesterol and triglycerides (P < 0.01). High-density lipoprotein (HDL) was significantly higher in HAART-naïve individuals while low-density lipoprotein was higher in the control group. Comparing HAART-exposed patients and HAART-naïve patients, significantly more HAART-naïve patients had lower HDL (abnormal), P = 0.04, odds ratio = 1.57, 95% confidence interval, 1.01–2.45. HAART-naïve patients had higher rates of abnormal results, except for fasting plasma glucose. Conclusion: HAART-exposed and HAART-naïve HIV/AIDS patients have a high level of dyslipidemia compared with normal HIV-negative patients, and this effect is more pronounced in male patients than female patients. There should be increased surveillance for metabolic derangements in these patients at the time of diagnosis and recruitment into the HAART program. There is a need for the treatment of dyslipidemia in such patients.https://doi.org/10.4103/ijmh.ijmh_15_24dyslipidemiaglycemic controlharrthiv/aidsnigeria |
| spellingShingle | Esther A. Ekwe Birinus A. Ezeala-Adikaibe Basden Onwubere Julius Okoye Collins Ugwu Chidinma B. Nwatu Ijoma Chinweuba Chidimma Orah-Okpala Raphael Anakwue Oladipupo O. Fasa Celestine C. Okwara Uchechi Q. Arinze Paschal Njoku Serum Lipid and Glycemic Profile in HARRT-Naïve and HARRT-Exposed HIV Patients in Enugu State, Nigeria: A Case–Control Study International Journal of Medicine and Health Development dyslipidemia glycemic control harrt hiv/aids nigeria |
| title | Serum Lipid and Glycemic Profile in HARRT-Naïve and HARRT-Exposed HIV Patients in Enugu State, Nigeria: A Case–Control Study |
| title_full | Serum Lipid and Glycemic Profile in HARRT-Naïve and HARRT-Exposed HIV Patients in Enugu State, Nigeria: A Case–Control Study |
| title_fullStr | Serum Lipid and Glycemic Profile in HARRT-Naïve and HARRT-Exposed HIV Patients in Enugu State, Nigeria: A Case–Control Study |
| title_full_unstemmed | Serum Lipid and Glycemic Profile in HARRT-Naïve and HARRT-Exposed HIV Patients in Enugu State, Nigeria: A Case–Control Study |
| title_short | Serum Lipid and Glycemic Profile in HARRT-Naïve and HARRT-Exposed HIV Patients in Enugu State, Nigeria: A Case–Control Study |
| title_sort | serum lipid and glycemic profile in harrt naive and harrt exposed hiv patients in enugu state nigeria a case control study |
| topic | dyslipidemia glycemic control harrt hiv/aids nigeria |
| url | https://doi.org/10.4103/ijmh.ijmh_15_24 |
| work_keys_str_mv | AT estheraekwe serumlipidandglycemicprofileinharrtnaiveandharrtexposedhivpatientsinenugustatenigeriaacasecontrolstudy AT birinusaezealaadikaibe serumlipidandglycemicprofileinharrtnaiveandharrtexposedhivpatientsinenugustatenigeriaacasecontrolstudy AT basdenonwubere serumlipidandglycemicprofileinharrtnaiveandharrtexposedhivpatientsinenugustatenigeriaacasecontrolstudy AT juliusokoye serumlipidandglycemicprofileinharrtnaiveandharrtexposedhivpatientsinenugustatenigeriaacasecontrolstudy AT collinsugwu serumlipidandglycemicprofileinharrtnaiveandharrtexposedhivpatientsinenugustatenigeriaacasecontrolstudy AT chidinmabnwatu serumlipidandglycemicprofileinharrtnaiveandharrtexposedhivpatientsinenugustatenigeriaacasecontrolstudy AT ijomachinweuba serumlipidandglycemicprofileinharrtnaiveandharrtexposedhivpatientsinenugustatenigeriaacasecontrolstudy AT chidimmaorahokpala serumlipidandglycemicprofileinharrtnaiveandharrtexposedhivpatientsinenugustatenigeriaacasecontrolstudy AT raphaelanakwue serumlipidandglycemicprofileinharrtnaiveandharrtexposedhivpatientsinenugustatenigeriaacasecontrolstudy AT oladipupoofasa serumlipidandglycemicprofileinharrtnaiveandharrtexposedhivpatientsinenugustatenigeriaacasecontrolstudy AT celestinecokwara serumlipidandglycemicprofileinharrtnaiveandharrtexposedhivpatientsinenugustatenigeriaacasecontrolstudy AT uchechiqarinze serumlipidandglycemicprofileinharrtnaiveandharrtexposedhivpatientsinenugustatenigeriaacasecontrolstudy AT paschalnjoku serumlipidandglycemicprofileinharrtnaiveandharrtexposedhivpatientsinenugustatenigeriaacasecontrolstudy |